We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

  • $ 4 995
  • Industry report
  • by GBI Research
  • August 2014
  • 105 pages

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM Summary GBI Research, the leading business intelligence provider, has released its latest research, "Glioblastoma Multiforme Therapeutics in ...

Industries: Therapy | Countries: Australia, India, Japan, China, World, United States, Asia, Oceania

Asia-Pacific Hernia Repair Market Outlook to 2020

Asia-Pacific Hernia Repair Market Outlook to 2020

  • $ 3 000
  • Industry report
  • by Global Data
  • July 2014
  • 126 pages

Asia-Pacific Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Hernia Repair Market Outlook to 2020", provides key market data on the Asia-Pacific Hernia Repair market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US ...

Industries: Pathology | Countries: South Korea, Australia, Japan, India, China, Asia, World, Oceania

Asia-Pacific Hernia Repair Procedures Outlook to 2020

Asia-Pacific Hernia Repair Procedures Outlook to 2020

  • $ 450
  • Industry report
  • by Global Data
  • July 2014
  • 341 pages

Asia-Pacific Hernia Repair Procedures Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Hernia Repair Procedures Outlook to 2020", provides key market data on the Asia-Pacific Hernia Repair Procedures. The report provides procedure volumes within market segments - Inguinal Hernia Repai ...

Industries: Pathology | Countries: South Korea, Australia, China, India, Japan, Asia, World, Oceania

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 63 pages

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, Oceania

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 60 pages

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 59 pages

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 60 pages

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 61 pages

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 45 pages

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • by Global Data
  • May 2014
  • 59 pages

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients ...

Industries: Pathology | Countries: Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.